表紙:ケロイド治療の世界市場レポート 2024年
市場調査レポート
商品コード
1415655

ケロイド治療の世界市場レポート 2024年

Keloids Treatment Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
ケロイド治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

ケロイド治療市場規模は近年力強く成長しています。2023年の39億1,000万米ドルから2024年には41億4,000万米ドルへとCAGR5.7%で拡大します。歴史的な期間の成長は、ケロイドの高い有病率、ケロイド治療に対する意識の高まり、創傷や怪我に関連するケースの発生率の増加、美容外科手術の増加に起因しています。

ケロイド治療市場の成長は、創傷や傷害ケースの発生率の上昇に牽引されています。創傷とは、身体組織への物理的損傷や危害を伴うもので、一般的に皮膚の断裂を伴い、事故、外科的処置、火傷、外傷性事象など様々な要因によって生じる。報告される傷の数の増加はケロイドの形成を助長し、それによって効果的な治療オプションへの需要を高めています。また、このような症例の急増は、ケロイド関連の合併症に対する意識の高まり、研究の進歩、医療専門家間の協力の促進にもつながっています。例えば、2022年11月に米国労働統計局が発表したデータによると、報告された傷害症例の総数は6.3%増加し、2020年の210万症例に比べ、2021年には220万症例に達しました。さらに、傷害発生率も上昇し、民間企業の雇用主が報告したフルタイム換算(FTE)労働者100人当たりの傷害発生件数は、2020年の2.2件から2021年には2.3件に増加しました。したがって、創傷および傷害事例の発生率の増加は、ケロイド治療市場の成長を促進すると予想されます。

2023年のケロイド治療市場では北米が最大地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。ケロイド治療レポートの対象地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界のケロイド治療市場、治療別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
  • 放射線治療
  • 凍結療法
  • 外科的治療
  • レーザー治療
  • ステロイド注射
  • インターフェロン
  • その他
  • 世界のケロイド治療市場、製品タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 弾性ラップ
  • スプレー
  • 軟膏
  • クリーム
  • オイル
  • 局所用ジェルおよびジェルシート
  • その他
  • 世界のケロイド治療市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 経口
  • 非経口
  • 世界のケロイド治療市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 在宅ケア
  • 皮膚科クリニック
  • その他

第7章 地域および国の分析

  • 世界のケロイド治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のケロイド治療市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • ケロイド治療市場の競合情勢
  • ケロイド治療市場の企業プロファイル
    • Pfizer Inc.
    • F. Hoffmann-La Roche Ltd.
    • Merck &Co. Inc.
    • Novartis AG
    • Bristol-Myers Squibb Company

第31章 その他の主要および革新的な企業

  • AstraZeneca plc
  • GlaxoSmithKline plc.
  • Eli Lilly and Company
  • Mylan N.V.
  • Galderma S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Molnlycke Health Care AB
  • Cynosure Inc.
  • Cutera Inc.
  • Alliance Pharma plc
  • Revance Therapeutics Inc
  • Sensus Healthcare
  • Strata Skin Sciences
  • Avita Medical Limited
  • Pacific World Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12254

“Keloids Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on keloids treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for keloids treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The keloids treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Treatment: Radiation Therapy; Cryo Therapy; Surgical Treatment; Laser Treatment; Steroid Injections; Interferon; Other Treatments
  • 2) By Product Type: Elastic Wraps; Sprays; Ointment; Creams; Oils; Topical Gels And Gel Sheets; Other Products
  • 3) By Route Of Administration: Oral; Parenteral
  • 4) By End User: Hospitals; Homecare; Dermatology Clinics; Other End Users
  • Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG; Bristol-Myers Squibb Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Keloids refer to raised, thickened scars that extend beyond the original boundaries of a wound or injury. These scars result from an overgrowth of collagen during the healing process, leading to a firm, often discolored and sometimes uncomfortable or itchy area on the skin. Keloids can be treated using various medical interventions and approaches tailored to the individual's condition and the severity of the keloid.

The main types of keloids treatment are radiation therapy, cryotherapy, surgical treatment, laser treatment, steroid injections, interferon and others. Radiation therapy is a medical treatment that uses high doses of targeted radiation to target and destroy abnormal cells, such as keloid cells, aiming to inhibit the overgrowth of cells and reduce the size of keloids, which helps prevent keloid recurrence by damaging the cells that contribute to their formation. Keloids treatment also includes products such as elastic wraps, sprays, ointments, creams, oils, topical gels and gel sheets and others administered orally and parenterally by end users such as hospitals, homecare, dermatology clinics and others.

The keloids treatment market research report is one of a series of new reports from The Business Research Company that provides keloids treatment market statistics, including keloids treatment industry global market size, regional shares, competitors with a keloids treatment market share, detailed keloids treatment market segments, market trends and opportunities and any further data you may need to thrive in the keloids treatment industry. This keloids treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The keloids treatment market size has grown strongly in recent years. It will grow from $3.91 billion in 2023 to $4.14 billion in 2024 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to high prevalence of keloids, growing awareness keloid treatments, increasing incidence of wound and injury-related cases, rise in aesthetic surgeries.

The keloids treatment market size is expected to see steady growth in the next few years. It will grow to $4.93 billion in 2028 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increasing expenditure on personal care products, government initiatives, increasing emphasis on scar prevention strategies, investments on keloids treatments. Major trends in the forecast period include advancements in treatment modalities, innovation in medical technologies, adanced minimally invasive procedures on keloids treatment, combination therapies, laser technology, scar management products.

Anticipated growth in the keloid treatment market is driven by the rising incidence of wound and injury cases. Wounds, which entail physical injury or harm to the body's tissues, typically involve breaks in the skin and result from various factors such as accidents, surgical procedures, burns, or traumatic events. The escalation in the number of reported wounds contributes to the formation of keloids, thereby increasing the demand for effective treatment options. This surge in cases also fosters heightened awareness regarding keloid-related complications, stimulates advancements in research, and encourages collaboration among medical professionals. For example, data from the U.S. Bureau of Labor Statistics in November 2022 revealed a 6.3% increase in the total reported injury cases, reaching 2.2 million cases in 2021, compared to 2.1 million cases in 2020. Furthermore, the injury rate rose, with private industry employers reporting 2.3 cases per 100 full-time equivalent (FTE) workers in 2021, up from 2.2 cases in 2020. Therefore, the growing incidence of wound and injury cases is expected to drive the growth of the keloid treatment market.

The Keloid Treatment Market is Anticipated to Grow Due to Increasing Interest in Non-Surgical Aesthetic Procedures. Non-surgical aesthetics, which are non-invasive cosmetic treatments aimed at improving one's appearance without surgery, are becoming increasingly popular. Healthcare providers utilize non-surgical aesthetic techniques such as laser therapy, cryotherapy, and dermal fillers to mitigate the appearance and symptoms of keloid scars, which can include reducing inflammation, redness, and vascularization. For example, statistics from the Aesthetic Society, a US-based organization specializing in plastic and cosmetic surgery, revealed a 44% increase in non-surgical procedures in 2021. Furthermore, the use of combination lasers and dermal fillers in procedures reached 431,485 and 1,857,339, respectively, in 2021, showing a 32% and 4% increase. This growing interest in non-surgical aesthetic treatments is expected to be a driving factor for the keloid treatment market's growth.

The growth of the keloid treatment market during the forecast period is hampered by the restricted treatment options. The effectiveness of keloid treatment is often constrained due to the limited availability of treatment modalities. This limitation is further exacerbated by the high rates of keloid recurrence and potential delays in seeking treatment. For instance, in 2023, according to the Mayo Foundation for Medical Education and Research (MFMER), a non-profit organization, the treatment options for keloids are limited, and surgery alone has a recurrence rate of 45% to 100% when keloids have not responded to other therapies. As a result, the limited treatment options act as a barrier to the growth of the keloid treatment market.

Prominent companies operating in the keloid treatment market are strategically focusing on the development of innovative scar management technologies, such as Scar Erase silicone strips, to attain a competitive edge. For instance, in April 2023, Scar Erase, a UK-based scar treatment company, introduced Scar Erase silicone strips as a solution for scar treatment. These strips, composed of 3 mm medical-grade silicone, have demonstrated clinical efficacy in enhancing scar appearance and facilitating healing. They are reusable, vegan, cruelty-free, and offer a convenient and cost-effective at-home scar treatment option suitable for various scar types, including hypertrophic, keloid, post-surgery, and stretch marks. The technology involves encapsulating the scar with silicone to maintain hydration and create an optimal healing environment. This approach reduces collagen formation, improves scar texture, color, and height, delivering both effectiveness and comfort.

In March 2022, Alliance Pharma PLC, a UK-based pharmaceutical company, completed the acquisition of ScarAway from Perrigo Co. PLC for $19.4 million. This acquisition empowered Alliance Pharma to strengthen its presence in the U.S. consumer healthcare market, diversify its product portfolio, establish a global brand, boost revenue, and solidify its position as a market leader in scar treatment. ScarAway, a U.S.-based scar treatment brand specializing in keloids, played a pivotal role in this strategic move.

Major players in the keloids treatment market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Company, Mylan N.V., Galderma S.A., Sun Pharmaceutical Industries Ltd., Molnlycke Health Care AB, Cynosure Inc., Cutera Inc., Alliance Pharma PLC, Revance Therapeutics Inc., Sensus Healthcare, Strata Skin Sciences, Avita Medical Limited, Pacific World Corporation, Mederma, Stratpharma AG, Sonoma Pharmaceuticals Inc., RXi Pharmaceuticals Inc., Biodermis, Novoxel Ltd., Scar Heal Inc., Galena Biopharma Inc.

North America was the largest region in the keloids treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in keloids treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the keloids treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, and Spain.

The keloids treatment market consists of revenues earned by entities by providing dermatology consultations, follow-up and monitoring and patient education and counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The keloids treatment market also includes sales of topical creams and gels, silicone sheets and patches and dermal fillers, which are used in keloids treatment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Keloids Treatment Market Characteristics

3. Keloids Treatment Market Trends And Strategies

4. Keloids Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Keloids Treatment Market Size and Growth

  • 5.1. Global Keloids Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Keloids Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Keloids Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Keloids Treatment Market Segmentation

  • 6.1. Global Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Radiation Therapy
  • Cryo Therapy
  • Surgical Treatment
  • Laser Treatment
  • Steroid Injections
  • Interferon
  • Other Treatments
  • 6.2. Global Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Elastic Wraps
  • Sprays
  • Ointment
  • Creams
  • Oils
  • Topical Gels And Gel Sheets
  • Other Products
  • 6.3. Global Keloids Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oral
  • Parenteral
  • 6.4. Global Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Dermatology Clinics
  • Other End Users

7. Keloids Treatment Market Regional And Country Analysis

  • 7.1. Global Keloids Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Keloids Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Keloids Treatment Market

  • 8.1. Asia-Pacific Keloids Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Keloids Treatment Market

  • 9.1. China Keloids Treatment Market Overview
  • 9.2. China Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Keloids Treatment Market

  • 10.1. India Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Keloids Treatment Market

  • 11.1. Japan Keloids Treatment Market Overview
  • 11.2. Japan Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Keloids Treatment Market

  • 12.1. Australia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Keloids Treatment Market

  • 13.1. Indonesia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Keloids Treatment Market

  • 14.1. South Korea Keloids Treatment Market Overview
  • 14.2. South Korea Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Keloids Treatment Market

  • 15.1. Western Europe Keloids Treatment Market Overview
  • 15.2. Western Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Keloids Treatment Market

  • 16.1. UK Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Keloids Treatment Market

  • 17.1. Germany Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Keloids Treatment Market

  • 18.1. France Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Keloids Treatment Market

  • 19.1. Italy Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Keloids Treatment Market

  • 20.1. Spain Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Keloids Treatment Market

  • 21.1. Eastern Europe Keloids Treatment Market Overview
  • 21.2. Eastern Europe Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Keloids Treatment Market

  • 22.1. Russia Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Keloids Treatment Market

  • 23.1. North America Keloids Treatment Market Overview
  • 23.2. North America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Keloids Treatment Market

  • 24.1. USA Keloids Treatment Market Overview
  • 24.2. USA Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Keloids Treatment Market

  • 25.1. Canada Keloids Treatment Market Overview
  • 25.2. Canada Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Keloids Treatment Market

  • 26.1. South America Keloids Treatment Market Overview
  • 26.2. South America Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Keloids Treatment Market

  • 27.1. Brazil Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Keloids Treatment Market

  • 28.1. Middle East Keloids Treatment Market Overview
  • 28.2. Middle East Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Keloids Treatment Market

  • 29.1. Africa Keloids Treatment Market Overview
  • 29.2. Africa Keloids Treatment Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Keloids Treatment Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Keloids Treatment Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Keloids Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Keloids Treatment Market Competitive Landscape
  • 30.2. Keloids Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck & Co. Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Novartis AG
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bristol-Myers Squibb Company
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Keloids Treatment Market Other Major And Innovative Companies

  • 31.1. AstraZeneca plc
  • 31.2. GlaxoSmithKline plc.
  • 31.3. Eli Lilly and Company
  • 31.4. Mylan N.V.
  • 31.5. Galderma S.A.
  • 31.6. Sun Pharmaceutical Industries Ltd.
  • 31.7. Molnlycke Health Care AB
  • 31.8. Cynosure Inc.
  • 31.9. Cutera Inc.
  • 31.10. Alliance Pharma plc
  • 31.11. Revance Therapeutics Inc
  • 31.12. Sensus Healthcare
  • 31.13. Strata Skin Sciences
  • 31.14. Avita Medical Limited
  • 31.15. Pacific World Corporation

32. Global Keloids Treatment Market Competitive Benchmarking

33. Global Keloids Treatment Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Keloids Treatment Market

35. Keloids Treatment Market Future Outlook and Potential Analysis

  • 35.1 Keloids Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Keloids Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Keloids Treatment Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer